MSI2 antisense RNA 1 (MSI2-AS1)

MSI2 antisense RNA 1 (MSI2-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the MSI2 locus. Its expression and functional data are limited, and it is distinct from the protein-coding MSI2 gene, which encodes the Musashi-2 RNA-binding protein. MSI2-AS1 may act as a regulatory RNA, possibly influencing the expression or splicing of MSI2, but definitive functions have not been consistently established across human tissues or diseases. While MSI2 (the protein) is a validated oncogenic RNA-binding protein involved in stem cell maintenance and cancer, MSI2-AS1 is not considered a canonical or therapeutic target, nor is it currently associated with drug discovery or established biomarker usage. Clarification: - If you meant MSI2, the well-established RNA-binding protein, see references for its role in cancer, stem/progenitor cell regulation, and other biological/pathological functions[1][2][3][6][7]. - MSI2-AS1 is only weakly described in databases and literature and should not be confused with MSI2, the protein and drug target. Note: - Most published research, including all major RNA-binding and cancer mechanistic work, focuses on MSI2 (Musashi-2 protein), not MSI2-AS1. - There is no strong evidence for MSI2-AS1 as a direct therapeutic target, with no drugs or clinical mechanisms explicitly targeting it. If you are seeking information for drug development or disease targeting, it is highly likely you are looking for \"Musashi-2 (MSI2),\" not MSI2 antisense RNA 1.

Other names

MSI2-AS1